QATCH Technologies is founded upon a technology developed at Duke University by Dr. Stefan Zauscher, who is Sternberg Family Professor of Mechanical Engineering & Materials Science at Duke University, and Dr. Zehra Parlak, a postdoctoral researcher at Zauscher Lab. Upon realizing the potential of the invention, Dr. Parlak founded QATCH Technologies in 2016.
QATCH Technologies applied for small business technology transfer (STTR) funding to National Science Foundation (NSF) to develop a state-of-art blood coagulation monitor with superior accuracy and reliability. NSF granted STTR funding in 2017. QATCH is collaborating with Zauscher Lab and medical doctors from Duke Hematology in this project.
QATCH's patent pending technology can characterize properties of nanoliters of liquid accurately in a few seconds. QATCH is building upon this technology by adding on-chip blood plasma separation capability. Blood plasma based tests have less interference problems compared to the whole blood tests and QATCH is planning to improve teh accuracy and reliability of blood coagulation tests by using this feature.